Structure and function of the bacterial decapping enzyme NudC [PDF]
RNA capping and decapping are thought to be distinctive features of eukaryotes. The redox cofactor NAD was recently discovered to be attached to small regulatory RNAs in bacteria in a cap-like manner, and Nudix hydrolase NudC was found to act as a NAD-decapping enzyme in vitro and in vivo.
Katharina Höfer +8 more
europepmc +5 more sources
Dcp2 C-terminal cis-binding elements control selective targeting of the decapping enzyme by forming distinct decapping complexes [PDF]
A single Dcp1–Dcp2 decapping enzyme targets diverse classes of yeast mRNAs for decapping-dependent 5′ to 3′ decay, but the molecular mechanisms controlling mRNA selectivity by the enzyme remain elusive. Through extensive genetic analyses we reveal that Dcp2 C-terminal domain cis -regulatory ...
Feng He, Chan Wu, Allan Jacobson
europepmc +6 more sources
The ApaH-like phosphatase TbALPH1 is the major mRNA decapping enzyme of trypanosomes [PDF]
5'-3' decay is the major mRNA decay pathway in many eukaryotes, including trypanosomes. After deadenylation, mRNAs are decapped by the nudix hydrolase DCP2 of the decapping complex and finally degraded by the 5'-3' exoribonuclease. Uniquely, trypanosomes lack homologues to all subunits of the decapping complex, while deadenylation and 5'-3' degradation
Kramer S.
europepmc +7 more sources
Dcp2: an mRNA decapping enzyme that adopts many different shapes and forms
Eukaryotic mRNAs contain a 5' cap structure that protects the transcript against rapid exonucleolytic degradation. The regulation of cellular mRNA levels therefore depends on a precise control of the mRNA decapping pathways. The major mRNA decapping enzyme in eukaryotic cells is Dcp2.
Jan Philip Wurm, Remco Sprangers
europepmc +5 more sources
An excess of catalytically required motions inhibits the scavenger decapping enzyme [PDF]
The scavenger decapping enzyme hydrolyzes the protective 5' cap structure on short mRNA fragments that are generated from the exosomal degradation of mRNAs. From static crystal structures and NMR data, it is apparent that the dimeric enzyme has to undergo large structural changes to bind its substrate in a catalytically competent conformation.
Ancilla Neu +4 more
europepmc +7 more sources
Molecular basis of the selective processing of short mRNA substrates by the DcpS mRNA decapping enzyme. [PDF]
The 5' messenger RNA (mRNA) cap structure enhances translation and protects the transcript against exonucleolytic degradation. During mRNA turnover, this cap is removed from the mRNA.
Fuchs AL, Wurm JP, Neu A, Sprangers R.
europepmc +2 more sources
Nudt3 is an mRNA decapping enzyme that modulates cell migration [PDF]
Removal of the 5′-end 7-methylguanosine cap structure is a critical step in the highly regulated process of mRNA decay. The Nudix hydrolase, Dcp2, was identified as a first decapping enzyme and subsequently shown to preferentially modulate stability of only a subset of mRNAs.
Grudzien-Nogalska, Ewa +4 more
openaire +3 more sources
Changes in conformational equilibria regulate the activity of the Dcp2 decapping enzyme [PDF]
Significance The Dcp2 decapping enzyme targets mRNA for degradation and thereby plays a role in the regulation of gene expression. Despite numerous static crystal structures of the enzyme, it remained unclear how its catalytic activity correlates with the relative domain orientation in Dcp2.
Jan Philip Wurm +4 more
openaire +5 more sources
Targeted Degradation of mRNA Decapping Enzyme DcpS by a VHL-Recruiting PROTAC [PDF]
The RNA decapping scavenger protein, DcpS, has recently been identified as a dependency in acute myeloid leukemia (AML). The potent DcpS inhibitor RG3039 attenuates AML cell viability, and shRNA knockdown of DcpS is also antiproliferative. Importantly, DcpS was found to be non-essential in normal human hematopoietic cells, which opens a therapeutic ...
Jake C. Swartzel +10 more
openaire +3 more sources
Characterization of the African Swine Fever Virus Decapping Enzyme during Infection [PDF]
ABSTRACT African swine fever virus (ASFV) infection is characterized by a progressive decrease in cellular protein synthesis with a concomitant increase in viral protein synthesis, though the mechanism by which the virus achieves this is still unknown.
Quintas, Ana +6 more
openaire +6 more sources

